"MedPharmics is a clinical research consortium with 8 sites located in Louisiana, Mississippi, Arizona, New Mexico, and Alabama. Our sites enlist “Medical Heroes” for clinical research trials to determine the efficacy and safety of new medications or devices while ensuring the safety and protection of our participants."

During the past decade, MedPharmics, LLC conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 2 clinical trials were completed. i.e. 13.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MedPharmics, LLC" #1 sponsor was "Pfizer" with 6 trials, followed by "BioNTech SE" with 3 trials sponsored, "Abbott Molecular" with 1 trials sponsored, "Abbott Nutrition" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MedPharmics, LLC" #1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "MedPharmics, LLC" are "COVID-19" (4 trials), "SARS-CoV-2 Infection" (3 trials), "Pneumococcal Disease" (2 trials), "Respiratory Tract Infection" (2 trials) and "COVID-19 Prevention" (1 trials). Many other conditions were trialed in "MedPharmics, LLC" in a lesser frequency.

Most popular intervention types in "MedPharmics, LLC" are "Biological" (12 trials), "Other" (5 trials), "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "BNT162b2" (3 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials) and "20vPnC" (1 trials). Other intervention names were less common.

The vast majority of trials in "MedPharmics, LLC" are 11 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "MedPharmics, LLC". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in MedPharmics, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MedPharmics, LLC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".